RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Fairway, KS · +41 more sites
3 recruiting alzheimer's disease studies with a site in Fairway, KS.
Sponsor: Eli Lilly and Company
Fairway, KS · +41 more sites
Sponsor: Novartis Pharmaceuticals
Fairway, KS · +23 more sites
Sponsor: University of Kansas Medical Center
Fairway, KS
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.